ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PINE Alpine Income Property Trust Inc

15.47
0.18 (1.18%)
After Hours
Last Updated: 16:01:20
Delayed by 15 minutes

Period:

Draw Mode:

Volume 74,770
Bid Price
Ask Price
News -
Day High 15.47

Low
14.25

52 Week Range

High
17.76

Day Low 15.14
Company Name Stock Ticker Symbol Market Type
Alpine Income Property Trust Inc PINE NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.18 1.18% 15.47 16:01:20
Open Price Low Price High Price Close Price Prev Close
15.35 15.14 15.47 15.47 15.29
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
735 74,770 $ 15.39 $ 1,150,476 - 14.25 - 17.76
Last Trade Time Type Quantity Stock Price Currency
16:10:00 8,111 $ 15.47 USD

Alpine Income Property Trust Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
210.4M 13.62M - 45.64M 2.92M 0.21 72.13
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Alpine Income Property News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PINE Message Board. Create One! See More Posts on PINE Message Board See More Message Board Posts

Historical PINE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week15.1015.4714.32514.8370,3680.372.45%
1 Month15.2215.5614.32515.1061,3060.251.64%
3 Months15.9416.20514.32515.4155,395-0.47-2.95%
6 Months14.4017.679914.2515.8458,4241.077.43%
1 Year16.0917.7614.2516.0171,415-0.62-3.85%
3 Years18.5021.06914.2517.7073,200-3.03-16.38%
5 Years19.0021.0697.5617.1169,809-3.53-18.58%

Alpine Income Property Description

Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202.

Your Recent History

Delayed Upgrade Clock